Evidence map›Paper›PMID 22159600›Full record

ArticleMolecular & cellular proteomics : MCP2012

Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Jerome Zoidakis, Manousos Makridakis, Panagiotis G Zerefos, Vasiliki Bitsika, Sergio Esteban, Maria Frantzi, Konstantinos Stravodimos, Nikolaos P Anagnou, Maria G Roubelakis, Marta Sanchez-Carbayo and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. A simple urine test by 3D-plus-3D immunoassay guides preciseBioengineering & translational medicine · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  13. Article
  14. Review
  15. Pharmacogenomics and personalized medicine · 2021
    Article
  16. Review
  17. Profilin choreographs actin and microtubules in cells and cancer.International review of cell and molecular biology · 2020
    Article
  18. Article
  19. Review
  20. Evaluation of a New Survivin ELISA and UBCInternational journal of molecular sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jerome ZoidakisBiotechnology Division, Biomedical Research Foundation, Academy of Athens, Greece.
Manousos Makridakis
Panagiotis G Zerefos
Vasiliki Bitsika
Sergio Esteban
Maria Frantzi
Konstantinos Stravodimos
Nikolaos P Anagnou
Maria G Roubelakis
Marta Sanchez-Carbayo
Antonia Vlahou
Biomedical Research Foundation of the Academy of Athens · GRAcademy of Athens · GRCentro de Investigación del Cáncer · ESNational and Kapodistrian University of Athens · GRSpanish National Cancer Research Centre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Of the most important clinical needs for bladder cancer (BC) management is the identification of biomarkers for disease aggressiveness. Urine is a "gold mine" for biomarker discovery, nevertheless, with multiple proteins being in low amounts, urine proteomics becomes challenging. In the present study we applied a fractionation strategy of urinary proteins based on the use of immobilized metal affinity chromatography for the discovery of biomarkers for aggressive BC. Urine samples from patients with non invasive (two pools) and invasive (two pools) BC were subjected to immobilized metal affinity chromatography fractionation and eluted proteins analyzed by 1D-SDS-PAGE, band excision and liquid chromatography tandem MS. Among the identified proteins, multiple corresponded to proteins with affinity for metals and/or reported to be phosphorylated and included proteins with demonstrated association with BC such as MMP9, fibrinogen forms, and clusterin. In agreement to the immobilized metal affinity chromatography results, aminopeptidase N, profilin 1, and myeloblastin were further found to be differentially expressed in urine from patients with invasive compared with non invasive BC and benign controls, by Western blot or Elisa analysis, nevertheless exhibiting high interindividual variability. By tissue microarray analysis, profilin 1 was found to have a marked decrease of expression in the epithelial cells of the invasive (T2+) versus high risk non invasive (T1G3) tumors with occasional expression in stroma; importantly, this pattern strongly correlated with poor prognosis and increased mortality. The functional relevance of profilin 1 was investigated in the T24 BC cells where blockage of the protein by the use of antibodies resulted in decreased cell motility with concomitant decrease in actin polymerization. Collectively, our study involves the application of a fractionation method of urinary proteins and as one main result of this analysis reveals the association of profilin 1 with BC paving the way for its further investigation in BC stratification.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorCD13 AntigensChromatography, AffinityChromatography, LiquidEpithelial CellsHumansMiddle AgedMyeloblastinNeoplasm InvasivenessNeoplasm ProteinsProfilinsStromal CellsTandem Mass SpectrometryBiomarkers, TumorCD13 AntigensMyeloblastinNeoplasm ProteinsPFN1 protein, humanProfilins

Identifiers

PMID22159600
PMCPMC3322560
OpenAlexW2154065963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.